100% tevredenheidsgarantie Direct beschikbaar na betaling Zowel online als in PDF Je zit nergens aan vast
logo-home
FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder $16.00   In winkelwagen

Tentamen (uitwerkingen)

FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder

 14 keer bekeken  0 keer verkocht
  • Vak
  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
  • Instelling
  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION

FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder

Voorbeeld 4 van de 368  pagina's

  • 25 september 2024
  • 368
  • 2024/2025
  • Tentamen (uitwerkingen)
  • Vragen en antwoorden
book image

Titel boek:

Auteur(s):

  • Uitgave:
  • ISBN:
  • Druk:
  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
avatar-seller
NurseJanetteRichardson
FULL TEST BANK
PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
____________________________________________________________________________________

By Linda Lane Lilley| Shelly Rainforth Collins| Snyder

,Table of Contents
PART 1: PHARMACOLOGY BASICS ................................................................................................................. 4
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY .................................................................... 4
CHAPTER 02: PHARMACOLOGIC PRINCIPLES ............................................................................................ 8
CHAPTER 03: LIFESPAN CONSIDERATIONS ............................................................................................. 16
CHAPTER 04: CULTURAL, LEGAL, AND ETHICAL CONSIDERATIONS ........................................................ 23
CHAPTER 05: MEDICATION ERRORS: PREVENTING AND RESPONDING ................................................. 30
CHAPTER 06: PATIENT EDUCATION AND DRUG THERAPY ...................................................................... 34
CHAPTER 07: OVER-THE-COUNTER DRUGS AND HERBAL AND DIETARY SUPPLEMENTS ....................... 39
CHAPTER 08: GENE THERAPY AND PHARMACOGENOMICS ................................................................... 44
CHAPTER 09: PHOTO ATLAS OF DRUG ADMINISTRATION ...................................................................... 47
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM ................................................................... 58
CHAPTER 10: ANALGESIC DRUGS ............................................................................................................ 58
CHAPTER 11: GENERAL AND LOCAL ANESTHETICS ................................................................................. 66
CHAPTER 12: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ........................... 70
CHAPTER 13: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS ................................... 76
CHAPTER 14: ANTIEPILEPTIC DRUGS ...................................................................................................... 81
CHAPTER 15: ANTIPARKINSON DRUGS ................................................................................................... 87
CHAPTER 16: PSYCHOTHERAPEUTIC DRUGS........................................................................................... 93
CHAPTER 17: SUBSTANCE USE DISORDER ............................................................................................ 101
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM........................................................... 107
CHAPTER 18: ADRENERGIC DRUGS ....................................................................................................... 107
CHAPTER 19: ADRENERGIC-BLOCKING DRUGS ..................................................................................... 113
CHAPTER 20: CHOLINERGIC DRUGS ...................................................................................................... 119
CHAPTER 21: CHOLINERGIC-BLOCKING DRUGS .................................................................................... 125
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS ............................................. 131
CHAPTER 22: ANTIHYPERTENSIVE DRUGS ............................................................................................ 131
CHAPTER 23: ANTIANGINAL DRUGS ..................................................................................................... 138
CHAPTER 24: HEART FAILURE DRUGS ................................................................................................... 145
CHAPTER 25: ANTIDYSRHYTHMIC DRUGS ............................................................................................ 151
CHAPTER 26: COAGULATION MODIFIER DRUGS .................................................................................. 158
CHAPTER 27: ANTILIPEMIC DRUGS ....................................................................................................... 165
CHAPTER 28: DIURETIC DRUGS ............................................................................................................. 171

, CHAPTER 29: FLUIDS AND ELECTROLYTES ............................................................................................ 177
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS ......................................... 184
CHAPTER 30: PITUITARY DRUGS ........................................................................................................... 184
CHAPTER 31: THYROID AND ANTITHYROID DRUGS .............................................................................. 188
CHAPTER 32: DIABETES DRUGS ............................................................................................................ 194
CHAPTER 33: ADRENAL DRUGS ............................................................................................................. 204
CHAPTER 34: WOMEN’S HEALTH DRUGS ............................................................................................. 209
CHAPTER 35: MEN’S HEALTH DRUGS.................................................................................................... 218
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM .......................................................................... 223
CHAPTER 36: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS ................. 223
CHAPTER 37: RESPIRATORY DRUGS ...................................................................................................... 229
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS .................................................................... 236
CHAPTER 38: ANTIBIOTICS PART 1 ........................................................................................................ 236
CHAPTER 39: ANTIBIOTICS PART 2 ........................................................................................................ 244
CHAPTER 40: ANTIVIRAL DRUGS ........................................................................................................... 250
CHAPTER 41: ANTITUBERCULAR DRUGS............................................................................................... 256
CHAPTER 42: ANTIFUNGAL DRUGS ....................................................................................................... 261
CHAPTER 43: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS ................................... 267
CHAPTER 44: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ............................................................. 272
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC AND IMMUNE MODIFIERS ................................. 279
CHAPTER 45: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC DRUGS
.............................................................................................................................................................. 279
CHAPTER 46: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC DRUGS AND
MISCELLANEOUS DRUGS ...................................................................................................................... 286
CHAPTER 47: BIOLOGIC RESPONSE–MODIFYING AND ANTIRHEUMATIC DRUGS ................................ 292
CHAPTER 48: IMMUNOSUPPRESSANT DRUGS ..................................................................................... 297
CHAPTER 49: IMMUNIZING DRUGS ...................................................................................................... 303
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION ..................................... 308
CHAPTER 50: ACID-CONTROLLING DRUGS ........................................................................................... 309
CHAPTER 51: BOWEL DISORDER DRUGS............................................................................................... 316
CHAPTER 52: ANTIEMETIC AND ANTINAUSEA DRUGS ......................................................................... 325
CHAPTER 53: VITAMINS AND MINERALS .............................................................................................. 331
CHAPTER 54: ANEMIA DRUGS............................................................................................................... 337
CHAPTER 55: NUTRITIONAL SUPPLEMENTS ......................................................................................... 345

, PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS .................................................................. 351
CHAPTER 56: DERMATOLOGIC DRUGS ................................................................................................. 351
CHAPTER 57: OPHTHALMIC DRUGS ...................................................................................................... 358
CHAPTER 58: OTIC DRUGS .................................................................................................................... 364



PART 1: PHARMACOLOGY BASICS
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY

MULTIPLE CHOICE

1. THE NURSE IS WRITING A NURSING DIAGNOSIS FOR A PLAN OF CARE FOR A PATIENT WHO HAS
BEEN NEWLY DIAGNOSED WITH TYPE 2 DIABETES. WHICH STATEMENT REFLECTS THE CORRECT FORMAT
FOR A NURSING DIAGNOSIS?

A. ANXIETY

B. ANXIETY RELATED TO NEW DRUG THERAPY

C. ANXIETY RELATED TO ANXIOUS FEELINGS ABOUT DRUG THERAPY, AS EVIDENCED BY
STATEMENTS SUCH AS “I’M UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”

D. ANXIETY RELATED TO NEW DRUG THERAPY, AS EVIDENCED BY STATEMENTS SUCH AS “I’M
UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”

CORRECT ANS>D

FORMULATION OF NURSING DIAGNOSES IS USUALLY A THREE-STEP PROCESS. “ANXIETY” IS MISSING
THE “RELATED TO” AND “AS EVIDENCED BY” PORTIONS OF DEFINING CHARACTERISTICS. “ANXIETY
RELATED TO NEW DRUG THERAPY” IS MISSING THE “AS EVIDENCED BY” PORTION OF DEFINING
CHARACTERISTICS. THE STATEMENT BEGINNING “ANXIETY RELATED TO ANXIOUS FEELINGS” IS
INCORRECT BECAUSE THE “RELATED TO” SECTION IS SIMPLY A RESTATEMENT OF THE PROBLEM
“ANXIETY,” NOT A SEPARATE FACTOR RELATED TO THE RESPONSE.

DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) TOP: NURSING PROCESS: NURSING
DIAGNOSIS

MSC: NCLEX: SAFE AND EFFECTIVE CARE ENVIRONMENT: MANAGEMENT OF CARE

2. THE PATIENT IS TO RECEIVE ORAL GUAIFENESIN (MUCINEX) TWICE A DAY. TODAY, THE NURSE
WAS BUSY AND GAVE THE MEDICATION 2 HOURS AFTER THE SCHEDULED DOSE WAS DUE. WHAT TYPE
OF PROBLEM DOES THIS REPRESENT?

A. “RIGHT TIME”

B. “RIGHT DOSE”

C. “RIGHT ROUTE”

Voordelen van het kopen van samenvattingen bij Stuvia op een rij:

Verzekerd van kwaliteit door reviews

Verzekerd van kwaliteit door reviews

Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!

Snel en makkelijk kopen

Snel en makkelijk kopen

Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.

Focus op de essentie

Focus op de essentie

Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!

Veelgestelde vragen

Wat krijg ik als ik dit document koop?

Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.

Tevredenheidsgarantie: hoe werkt dat?

Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.

Van wie koop ik deze samenvatting?

Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper NurseJanetteRichardson. Stuvia faciliteert de betaling aan de verkoper.

Zit ik meteen vast aan een abonnement?

Nee, je koopt alleen deze samenvatting voor $16.00. Je zit daarna nergens aan vast.

Is Stuvia te vertrouwen?

4,6 sterren op Google & Trustpilot (+1000 reviews)

Afgelopen 30 dagen zijn er 79223 samenvattingen verkocht

Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen

Start met verkopen
$16.00
  • (0)
  Kopen